231 related articles for article (PubMed ID: 2553899)
21. Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the rat.
Kubota E; Dean RG; Hubner RA; Casley DJ; Johnston CI; Burrell LM
Clin Sci (Lond); 2003 Sep; 105(3):339-45. PubMed ID: 12741953
[TBL] [Abstract][Full Text] [Related]
22. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA
Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935
[TBL] [Abstract][Full Text] [Related]
23. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
24. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
Zhuo J; Casley D; Murone C; Mendelsohn FA
J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue.
Fabris B; Chen BZ; Pupic V; Perich R; Johnston CI
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S6-13. PubMed ID: 1691409
[TBL] [Abstract][Full Text] [Related]
26. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
27. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
28. Effect of zinc depletion on angiotensin I-converting enzyme in arterial walls and plasma of the rat.
Dahlheim H; White CL; Rothemund J; von Lutterotti N; Jacob IC; Rosenthal J
Miner Electrolyte Metab; 1989; 15(3):125-9. PubMed ID: 2542744
[TBL] [Abstract][Full Text] [Related]
29. Effects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography.
Sakaguchi K; Jackson B; Chai SY; Mendelsohn FA; Johnson CI
J Cardiovasc Pharmacol; 1988 Dec; 12(6):710-7. PubMed ID: 2467090
[TBL] [Abstract][Full Text] [Related]
30. Acute and chronic effects of perindopril on tissue angiotensin converting enzyme activity.
Mendelsohn FA; Pupic V; Jackson B; Cubela R; Johnston CI
Am J Hypertens; 1991 Mar; 4(3 Pt 2):220S-225S. PubMed ID: 1645981
[TBL] [Abstract][Full Text] [Related]
31. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
[TBL] [Abstract][Full Text] [Related]
32. Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation.
Torsello A; Locatelli V; Cella SG; Sanguini AM; Berti F
J Endocrinol Invest; 2003 Jan; 26(1):79-83. PubMed ID: 12602539
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril.
Sun Y; Mendelsohn FA
J Cardiovasc Pharmacol; 1991 Oct; 18(4):478-86. PubMed ID: 1724523
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of αS1- and αS2-casein hydrolysates on angiotensin I-converting enzyme in human endothelial cells in vitro, rat aortic tissue ex vivo, and renovascular hypertensive rats in vivo.
Rousseau-Ralliard D; Goirand F; Tardivel S; Lucas A; Algaron F; Mollé D; Robert V; Auchère D; Boudier JF; Gaillard JL; Monnet V; Tauzin J; Grynberg A
J Dairy Sci; 2010 Jul; 93(7):2906-21. PubMed ID: 20630208
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme inhibition by hydroxamic zinc-binding idrapril in humans.
Zanchi A; Nussberger J; Criscuoli M; Capone P; Brunner HR
J Cardiovasc Pharmacol; 1994 Aug; 24(2):317-22. PubMed ID: 7526067
[TBL] [Abstract][Full Text] [Related]
36. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
37. Effect of angiotensin-converting enzyme inhibitors on non-diseased myocardium of experimental animals: potential clinical implications.
Simko F; Pechanova O; Bernatova I; Pelouch V
Med Hypotheses; 2000 Apr; 54(4):626-7. PubMed ID: 10859652
[TBL] [Abstract][Full Text] [Related]
38. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
[TBL] [Abstract][Full Text] [Related]
39. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
King JN; Mauron C; Kaiser G
Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
